Perimeter Medical Imaging AI (PINK) AI Stock Analysis

• Market Cap: C$37.22M
• Dividend Yield: N/A
• Average Volume (3M): 55.39K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.73
• Revenue Growth: 209.29%
• EPS Growth: 35.38%
• Country: CA
• Employees: 65
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): -0.04
• Shares Outstanding: 106,355,255
• 10 Day Avg. Volume: 68,307
• 30 Day Avg. Volume: 55,392
• PEG Ratio: 0.06
• Price to Book (P/B): 2.60
• Price to Sales (P/S): 32.11
• P/FCF Ratio: -1.61
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: C$0.29 ▲(3.21% Upside)

The overall stock score is primarily impacted by financial performance challenges, including negative profitability and cash flow issues. While technical analysis shows bullish momentum, the valuation reflects ongoing losses, limiting the stock's attractiveness.

Positive Factors

Low leverage

Very low debt levels provide financial flexibility for a medical-device company during commercialization. This reduces insolvency risk, helps fund R&D and installations without heavy interest burdens, and supports sustaining operations during the scale-up phase.

Healthy gross margin

A ~56.6% gross margin indicates strong unit economics for the OCT system and consumables. Durable product-level margins can support investments in AI, service and market expansion while enabling operating leverage as recurring consumable and service revenue scales.

Sustained revenue growth

Mid-teens to low-twenties revenue growth shows adoption in hospitals and surgical centers; persistent top-line expansion validates product-market fit and underpins future recurring service and consumable revenues that are crucial for long-term margin improvement.

Negative Factors

Negative operating cash flow

Ongoing negative operating and free cash flow imply the company relies on external financing to sustain operations and rollouts. Persistent cash burn raises execution risk for commercialization, increasing the chance of dilution or constrained investment if growth slows.

Unprofitable at operating level

Negative EBIT and net margins show the company has yet to convert healthy gross margins into operating profitability. Without disciplined cost control or faster revenue scale, persistent losses will pressure cash resources and delay sustainable free cash flow generation.

Negative return on equity

Negative ROE indicates current capital deployment isn't generating shareholder returns. Over time this signals capital inefficiency and raises concerns about management's ability to scale profitably, potentially complicating future fundraising and capital allocation decisions.

Perimeter Medical Imaging AI Business Overview & Revenue Model

Company Description

Perimeter Medical Imaging AI (PINK) is a pioneering company in the medical imaging sector, focusing on the integration of artificial intelligence with advanced imaging technologies to enhance surgical precision and patient outcomes. The company specializes in the development of innovative imaging solutions that aid in the intraoperative assessment of cancerous tissues, providing surgeons with real-time information during procedures. Its flagship products include the Perimeter S-Series OCT imaging system, which utilizes optical coherence tomography to deliver high-resolution images of tissue margins, ultimately aiming to reduce re-excision rates and improve surgical effectiveness.

How the Company Makes Money

Perimeter Medical Imaging AI generates revenue primarily through the sales of its imaging systems and associated consumables to hospitals and surgical centers. The company also earns income from ongoing service agreements and maintenance contracts for its devices. Additionally, Perimeter may derive revenue through partnerships and collaborations with healthcare institutions and research organizations that are interested in utilizing its technology for clinical studies or integration into their surgical workflows. The adoption of its products and technology within the healthcare sector, alongside potential licensing agreements for its AI algorithms, further contributes to its financial growth.

Perimeter Medical Imaging AI Financial Statement Overview

Summary

Perimeter Medical Imaging AI is experiencing revenue growth, but faces significant profitability challenges. The company has a healthy gross profit margin but struggles with negative net profit margins and EBIT margins. The balance sheet shows low leverage, yet negative cash flow and return on equity highlight the need for strategic improvements.

Income Statement

Perimeter Medical Imaging AI has shown some revenue growth, with a TTM revenue growth rate of 21.04%. However, the company is struggling with profitability, as indicated by negative net profit margins and EBIT margins. The gross profit margin is relatively healthy at 56.55%, but the company needs to address its high operating losses to improve its financial health.

Balance Sheet

The company maintains a low debt-to-equity ratio of 0.021, indicating low leverage, which is a positive aspect. However, the return on equity is negative, reflecting ongoing losses and inefficiencies in generating returns for shareholders. The equity ratio is not explicitly calculated, but the low debt levels suggest a stable capital structure.

Cash Flow

Cash flow analysis reveals challenges, with negative operating cash flow and free cash flow. The free cash flow to net income ratio is slightly above 1, indicating that the company is generating some cash relative to its net losses. However, the negative growth in free cash flow and high cash burn rate are concerning.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.89M	846.19K	403.53K	132.77K	11.34K	0.00
Gross Profit	1.07M	535.11K	206.42K	100.63K	5.04K	-47.57K
EBITDA	-13.49M	-12.64M	-18.13M	-11.72M	-15.95M	-6.11M
Net Income	-15.37M	-13.39M	-18.94M	-3.59M	-16.76M	-8.00M
Balance Sheet
Total Assets	5.99M	14.33M	27.09M	34.60M	9.98M	13.16M
Cash, Cash Equivalents and Short-Term Investments	2.35M	6.18M	18.43M	28.44M	5.14M	11.70M
Total Debt	101.75K	137.48K	192.89K	325.68K	441.17K	400.81K
Total Liabilities	2.51M	3.87M	7.10M	8.49M	2.56M	2.40M
Stockholders Equity	4.84M	10.45M	15.06M	26.11M	7.42M	10.76M
Cash Flow
Free Cash Flow	-12.78M	-16.90M	-15.17M	-13.86M	-16.03M	-8.26M
Operating Cash Flow	-10.99M	-14.72M	-14.70M	-11.87M	-13.91M	-8.26M
Investing Cash Flow	-1.71M	-1.90M	206.01K	-1.75M	-1.45M	7.24M
Financing Cash Flow	4.77M	8.58M	234.47K	40.28M	10.06M	9.84M

Perimeter Medical Imaging AI Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.28
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:PINK, the sentiment is Positive. The current price of 0.28 is below the 20-day moving average (MA) of 0.35, above the 50-day MA of 0.26, and below the 200-day MA of 0.28, indicating a bullish trend. The MACD of 0.02 indicates Positive momentum. The RSI at 56.36 is Neutral, neither overbought nor oversold. The STOCH value of 56.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:PINK.

Perimeter Medical Imaging AI Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
VPT	50 Neutral	C$20.96M	-5.04	―	―	28.59%	23.46%
PINK	46 Neutral	C$37.22M	-1.67	-181.70%	―	209.29%	35.38%
ASG	46 Neutral	C$19.51M	-10.33	-31.12%	―	9.71%	-118.02%
TLT	46 Neutral	C$68.12M	-15.14	-269.41%	―	1.46%	6.91%
PMED	46 Neutral	C$10.34M	-7.25	―	―	―	9.21%

Perimeter Medical Imaging AI Corporate Events

Perimeter Medical Imaging AI Strikes Systemwide Deployment Deal with Intermountain Health

Perimeter Medical Imaging AI has entered a systemwide agreement with Intermountain Health that allows deployment of its S-Series OCT intraoperative imaging technology across the nonprofit health system’s 34 hospitals and 400 clinics in the Intermountain West, starting with operating rooms at LDS Hospital in Salt Lake City and American Fork Hospital in Utah. The collaboration expands Perimeter’s footprint into several western states where its technology has not previously been used, deepens its existing relationship with Intermountain, and positions the company to support more surgeons with advanced imaging tools that aim to improve real-time margin assessment and patient outcomes while generating additional data to advance its AI-driven imaging algorithms.

The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.34 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.

Perimeter Medical Imaging AI Shareholders Back Board Slate and Expanded Incentive Plan

Perimeter Medical Imaging AI reported that shareholders approved all items at its annual general and special meeting, including the election of four directors to its board after the post-meeting resignation of Michelle Caron for personal reasons, and the appointment of KPMG LLP as auditor. Investors also backed a significant amendment to the company’s omnibus equity incentive plan, raising the pool of shares available for equity-based compensation to 20% of outstanding common shares, subject to final TSX Venture Exchange approval, a move that strengthens its ability to attract and retain talent as it advances its AI-powered B-Series platform toward anticipated regulatory milestones in 2026.

The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.34 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.

Perimeter Medical Imaging AI Secures C$3.6 Million to Boost Commercialization Efforts

Perimeter Medical Imaging AI has successfully closed a C$3.6 million non-brokered private placement, led by insiders including CEO Adrian Mendes. The capital raised will be used to accelerate the commercialization of the current S-Series device and bolster the company’s financial position as it awaits an FDA decision on its upcoming AI-powered B-Series, expected in the first half of 2026. This strategic move is anticipated to drive significant growth opportunities, positioning Perimeter’s imaging solutions as a transformative technology in operating rooms. The company plans to use the proceeds for continued product development, commercialization, and general corporate purposes.

The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.

Perimeter’s S-Series OCT Technology Adopted by HCA HealthONE Rose in Colorado

Perimeter Medical Imaging AI announced that HCA HealthONE Rose in Colorado is the first in the state to adopt its S-Series OCT imaging technology for surgical use. This adoption marks a significant expansion of Perimeter’s commercial footprint, enhancing surgical care by providing surgeons with advanced imaging capabilities to visualize tissue at the cellular level, potentially reducing the need for additional procedures.

The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.

Perimeter Medical Imaging AI Reports Robust Q3 2025 Financial Results Amidst Growing Market Traction

Perimeter Medical Imaging AI reported strong financial results for Q3 2025, with significant revenue growth and reduced operating expenses. The company’s S-Series device is gaining traction in top medical centers, contributing to a 157% year-over-year revenue increase. The upcoming B-Series, which is under FDA review, promises to further enhance the company’s market position by offering AI-powered imaging solutions. The company is at a pivotal point, expanding clinical adoption and preparing for the commercialization of its innovative technologies, which could transform surgical care standards.

The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.

Perimeter Medical Imaging AI to Announce Q3 2025 Financial Results

Perimeter Medical Imaging AI announced it will release its third quarter 2025 financial results on November 12, 2025, followed by a conference call to discuss the outcomes and provide a corporate update. This announcement is significant as it provides stakeholders with insights into the company’s financial health and operational progress, potentially impacting its market positioning and investor confidence.

The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.

Perimeter Medical Imaging AI Engages in Strategic Breast Surgery Forum

Perimeter Medical Imaging AI announced its participation in the American Society of Breast Surgeons’ Annual Strategic Futures Forum, a key event for healthcare leaders to discuss the future of breast surgery. This involvement allows Perimeter to engage with leaders in the breast surgeon community, potentially influencing their product development and enhancing breast care solutions. The forum’s theme emphasizes the importance of multi-disciplinary collaboration in improving breast care outcomes.

The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.

Perimeter Medical Imaging AI to Present at Planet MicroCap Showcase

Perimeter Medical Imaging AI announced its participation in the Planet MicroCap Showcase in Toronto, where CEO Adrian Mendes will present updates on the company’s commercial strategy and upcoming milestones. This event, which gathers investors and analysts, provides Perimeter with an opportunity to enhance its industry positioning and engage with potential stakeholders, highlighting its focus on advanced imaging tools for cancer surgery.

The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.

Perimeter Medical Imaging AI to Present at Virtual Investor Conference

Perimeter Medical Imaging AI announced that its CEO, Adrian Mendes, will present an update on the company’s business at the Small Cap Growth Virtual Investor Conference. This presentation is significant as it targets a global audience of small-cap retail and institutional investors, potentially impacting the company’s visibility and investor relations. The company’s focus on advanced imaging tools for cancer surgery positions it strategically within the medical technology industry, with ongoing evaluations and developments that could influence its market presence.

The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.